INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE;UNIVERSITÉ PARIS DIDEROT - PARIS 7;E;URGO RECHERCHE INNOVATION ET DÉVELOPPEMENT;Centre National de la Recherche Scientifique-CNRS CNRS
发明人:
Claire Dugast-Darzacq,Maite Noizet,Xavier Darzacq
申请号：
US14909626
公开号：
US20160168565A1
申请日:
2014.07.30
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to a therapeutic compound comprising: an agent that inhibits the activity of at least one gene selected from the group consisting of HIC1, FOXS1, CREB5, IRF7, POU2F2, STAT4, TCF4, and/or an agent that enhances the activity of at least one gene selected from the group consisting of MAF, MEOX2, SIX2.
